Nationwide Children’s gene therapy spinoff ‘crazy fast’ with early findings, raises $400K

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Milo Biotechnology LLC, a Nationwide Children’s Hospital spinoff that has raised $400,000, is progressing “crazy fast” toward applying for regulatory approval for a gene therapy for muscular dystrophy and other muscle-wasting disorders, its CEO said.

Click here to read the complete article.

Originally published June 15, 2016.